Provided by Tiger Fintech (Singapore) Pte. Ltd.

TherapeuticsMD

1.12
-0.0500-4.27%
Post-market: 1.170.0500+4.46%19:09 EDT
Volume:27.87K
Turnover:31.60K
Market Cap:12.96M
PE:-6.00
High:1.19
Open:1.18
Low:1.11
Close:1.17
Loading ...

TherapeuticsMD Inc. Reports Q1 2025: Net Loss Narrows to $636K, License Revenue Increases 25.8%

Reuters
·
14 May

TherapeuticsMD Inc: Continues to Evaluate a Variety of Strategic Alternatives

THOMSON REUTERS
·
14 May

Press Release: TherapeuticsMD Announces First Quarter 2025 Financial Results

Dow Jones
·
14 May

TherapeuticsMD Inc. Stock Rises Monday, Still Underperforms Market

Dow Jones
·
13 May

TherapeuticsMD Inc. Stock Rises 4.3%, Outperforms Market

Dow Jones
·
10 May

TherapeuticsMD Inc. Stock Underperforms Wednesday When Compared To Competitors

Dow Jones
·
08 May

TherapeuticsMD Inc. Stock Outperforms Competitors Despite Losses On The Day

Dow Jones
·
07 May

TherapeuticsMD Inc. Stock Underperforms Friday When Compared To Competitors Despite Daily Gains

Dow Jones
·
03 May

TherapeuticsMD Inc. Stock Advances 12.1%, Outperforms Market

Dow Jones
·
02 May

TherapeuticsMD Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
29 Apr

TherapeuticsMD Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
25 Apr

TherapeuticsMD Inc. Stock Advances 11.4%, Outperforms Market

Dow Jones
·
23 Apr

TherapeuticsMD Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
18 Apr

TherapeuticsMD Inc. Stock Underperforms Wednesday When Compared To Competitors

Dow Jones
·
17 Apr

TherapeuticsMD Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
15 Apr

TherapeuticsMD Inc. Stock Climbs 13.0%, Outperforms Market

Dow Jones
·
12 Apr

Mayne Pharma Faces Legal Challenge from TherapeuticsMD

TIPRANKS
·
11 Apr

Mayne Pharma Group Served With Legal Proceedings Against US Unit

MT Newswires Live
·
11 Apr

BRIEF-Therapeuticsmd - Files Lawsuit Against Mayne Pharma For Breach Of Contract

Reuters
·
09 Apr

TherapeuticsMD Inc - Files Lawsuit Against Mayne Pharma for Breach of Contract - SEC Filing

THOMSON REUTERS
·
09 Apr